← Back to Clinical Trials
Recruiting Phase 4 NCT07158476

Efficacy of Methylprednisolone for Pain Control After ACL Repair

Trial Parameters

Condition ACL Surgery
Sponsor St. Louis University
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 90
Sex ALL
Min Age 13 Years
Max Age 50 Years
Start Date 2025-10-21
Completion 2030-09
Interventions
Meloxicam 15 mgMedrol 4 MG Oral Tablet Includes Medrol DosepakGabapentin 300 mg

Brief Summary

Opioids are commonly used after orthopedic surgery for pain control but have been shown to increase complications, surgeries, readmissions, and risk for opioid use disorder. The purpose of this study is to investigate the impact of adding a methylprednisolone taper to the pain regimen after ACL repair surgery to determine if this results in decreased postoperative pain and opioid use without increasing complications.

Eligibility Criteria

Inclusion Criteria: * Patient undergoing ACL repair or ACL reconstruction with tendon autograft * Age 13-50 years old * Able to provide informed consent or parent/legal guardian is able for minors Exclusion Criteria: * Concurrent and significant injury to other bones or organs (Injury Severity Score of 4 or greater) * Revision ACL reconstruction * Concomitant additional ligament reconstruction or high tibial osteotomy * A history of alcohol abuse, substance abuse or chronic opioid use (filled opioid medication ×2 within 6 months of the surgery) * A history of renal failure (\<60 mL/min/1.73 m2), liver dysfunction (child class, \>B), severe heart disease (NYHA Class 4), diabetes, neurological or psychiatric diseases that may affect pain perception, and pre-existing immune suppression. * A history or active peptic ulcer disease, gastrointestinal bleeding, or current use of anticoagulation. * Patients currently taking oral or injectable glucocorticoids and those who have taken either with

Related Trials